baber/WOPTO huggingface dataset:
Patent NZ-577966-A (NZ)
Title: Manufacture of high-strength, low-salt sodium hypochlorite bleach
Inventor: POWELL DUANE J
IPC: C01B11/04
Filed: 2007-12-28
Abstract: Disclosed is a method for the continuous manufacture of higher-strength, lower-salt, aqueous sodium hypochlorite bleach from a lower-strength aqueous sodium hypochlorite bleach that has some sodium hydroxide and that is essentially free of sodium chloride (salt) crystals, the method comprising: A) in a tank, sustaining a continuous reaction that produces a slurry of higher strength bleach and solid salt crystals by introducing into the tank 1) the lower-strength aqueous sodium hypochlorite bleach that has some sodium hydroxide and is essentially free of salt crystals, 2) aqueous sodium hydroxide solution having a concentration by weight within a range from about 45% to about 51%, and 3) chlorine in gas and/or liquid phase that mayor may not include inerts, and 4) a recycle solution; B) continuously withdrawing slurry from the tank at a level below where the lower-strength bleach, the sodium hydroxide solution, the chlorine, and the recycle solution begin to mix with slurry already in the tank; C) cooling a first portion of the withdrawn slurry and using the cooled first portion of the withdrawn slurry as the recycle solution; and D) processing a second portion of the withdrawn slurry to separate substantially all salt crystals from the second portion of the withdrawn slurry to form a residual liquid; and E) recovering the residual liquid as the higher-strength lower-salt, aqueous sodium hypochlorite bleach.
Patent NZ-591329-A (NZ)
Title: Improvements in ocean wave energy extraction
Inventor: DENNISS TOM
IPC: E02B9/08
Filed: 2009-08-31
Abstract: 591329 Disclosed is an ocean wave energy extraction system. The system has at least one duct (203) for receiving an oscillating water column, the ducts (203) having a first segment, a second segment arranged transversely to the first segment and a flow control segment (207) intermediate the first and second segments. The flow control segment (207) has a sloped portion which inhibits turbulent flow of the oscillating water column flowing within the duct (203), the sloped portion having a planar surface extending between the first and second segments. An air-driven turbine (216) is in fluid communication with the second segment of the duct (203), the turbine (216) being driven to rotate unidirectionally by a bidirectional airflow generated by oscillations of the oscillating water column within the duct. An electric generator is configured for rotation by the turbine (216) to generate electrical energy.
Patent NZ-594180-A (NZ)
Title: Fluidic oscillator comprising at least one turbulent flow passage that is used to guide fluid flow for generating spray
Inventor: CHENG MENGFENG
IPC: B05B7/08
Filed: 2011-07-20
Abstract: A fluidic oscillator is disclosed. The oscillator comprises at least one channel (10) and at least one turbulent flow passage (14). The at least one channel (10) includes an interacting cavity (11). There is a first inlet (12) that communicates with the interactive cavity (11) to flow fluid inward and a first outlet (13) that communicates with the interacting cavity (11) to spray the fluid flowing through the interacting cavity (11) outward. The at least one turbulent flow passage (14) is used to guide a fluid in the turbulent passage (14) to flow into the interacting cavity or cavities (11), to interact with the fluid from the first inlet(s) (12), from one of the two opposite first longitudinal walls of the interacting cavity or cavities (11). This causes a turbulent flow effect to be generated in the interacting cavity or cavities (11). Then the fluid in the interaction cavity or cavities (11) flows out of the first outlet(s) (13) to generate oscillatory spray.
Patent NZ-595208-A (NZ)
Title: Binary and tertiary galvanic particulates and methods of manufacturing and use thereof
Inventor: SUN YING
IPC: A61K33/244
Filed: 2010-03-25
Abstract: 595208 The present disclosure relates to galvanic particulates, their methods of manufacture and uses in treatments are described. The galvanic particulates comprising a second conductive material dispersed in a first conductive material as in Fig. 6, the galvanic particulates may be used to treat for example: inflammation, infections, wrinkles, wound healing, acne and dermatitis. Examples of combinations of first conductive materials and second conductive materials include (with a "/" sign representing an oxidized but essentially non-soluble form of the metal), but are not limited to, zinc - copper, zinc-copper/copper halide, zinc-copper/copper oxide, magnesium-copper, magnesiumcopper/ copper halide, zinc-silver, zinc-silver/silver oxide, zinc-silver/silver halide, zinc-silver/silver chloride, zinc-silver/silver bromide, zinc-silver/silver iodide, zinc-silver/silver fluoride, zinc-gold, zinccarbon, magnesium-gold, magnesium-silver, magnesium-silver/silver oxide, magnesium-silver/silver halide, magnesium-silver/silver chloride, magnesium-silver/silver bromide, magnesium-silver/silver iodide, magnesium-silver/silver fluoride, magnesium-carbon, aluminum-copper, aluminum-gold, aluminum-silver, aluminum-silver/silver oxide, aluminum-silver/silver halide, aluminum-silver/silver chloride, aluminum-silver/silver bromide, aluminum-silver/silver iodide, aluminum-silver/silver fluoride, aluminum-carbon, copper-silver/silver halide, copper-silver/silver chloride, coppersilver/ silver bromide, copper-silver/silver iodide, copper-silver/silver fluoride, iron-copper, ironcopper/ copper oxide, copper-carbon iron-copper/copper halide, iron-silver, iron-silver/silver oxide, iron-silver/silver halide, iron-silver/silver chloride, iron-silver/silver bromide, iron-silver/silver iodide, iron-silver/silver fluoride, iron-gold, iron-conductive carbon, zinc-conductive carbon, copperconductive carbon, magnesium-conductive carbon, and aluminum-carbon.
Patent NZ-596558-A (NZ)
Title: Wet paint coating thickness measurement and instrument
Inventor: BUCHER UDO WOLFGANG
IPC: C23C2/14
Filed: 2010-05-25
Abstract: An instrument and a method for measuring the thickness of a paint coating on a rotating roll of a roll coating applicator for determination of the thickness of a paint coating to be applied to a moving substrate are disclosed. The instrument comprises sensor means arranged for emitting and detecting signals reflected from the surface of the paint coating on at least one roll of the roll coating applicator to generate data indicative of the position of the surface of the paint on the roll and processing means for processing the data generated by the sensor means to determine the thickness of the paint coating to be applied to the substrate. The sensor means is distanced from the paint coating for the emission and detection of the signals; .
Patent NZ-599404-A (NZ)
Title: Processes and intermediates for the preparation of 1’-substituted carba-nucleoside analogs
Inventor: BUTLER THOMAS
IPC: C07H1/00
Filed: 2010-09-20
Abstract: Disclosed is a method for preparing pyrrolo[1,2-f][1,2,4]triazinyl, imidazo[1,5-f][1,2,4]triazinyl, imidazo[l1,2-f][1,2,4]triazinyl, and [1,2,4]triazolo[4,3-f][1,2,4]triazinyl nucleosides of Formula I or an acceptable salt, thereof wherein the variables are defined in the specification said method comprising (a) providing a compound of formula II e.g. 3,4-bisbenzyloxy-5-benzyloxymethyl-2-(2,4-diamino-imidazo[2,1-f][1 ,2,4]triazin-7-yl)-3-methyl-tetrahydro-furan-2-ol or an acceptable salt thereof wherein the variables are defined in the specification (b) treating the compound of Formula II with a cyanide reagent and a Lewis acid thereby forming the compound of Formula I.
Patent NZ-602548-A (NZ)
Title: Oligomer-specific amyloid beta epitope and antibodies
Inventor: CASHMAN NEIL R
IPC: A61P37/04
Filed: 2011-03-03
Abstract: Disclosed is an isolated antibody that specifically binds to a cyclic peptide derived from Αβ, wherein the cyclic peptide comprises a conformational epitope having an amino acid sequence of at least SNK, wherein the K (Lysine) is solvent-accessible, and wherein the antibody binds to an oligomeric form of Αβ with greater affinity than to a non-oligomeric form of Αβ. Also disclosed it the use of such an antibody in the manufacture of a medicament for the treatment or prevention of Alzheimer’s disease.
Patent NZ-602754-A (NZ)
Title: Substituted 1,3-benzothiazepines useful in treating metabolic disorders
Inventor: AQUINO CHRISTOPHER JOSEPH
IPC: A61K31/554
Filed: 2011-04-27
Abstract: 602754 Provided are dioxido-phenyl-benzothiazepin derivatives of formula (I), where Q, R1, R2, R3, R4 and X are as defined in the specification. An example of the derivatives is 3-({ [(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]carbonyl} amino)-2,2-dimethylpropanoic acid. Methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and therapeutic uses of them are further provided. These compounds are suitable for treating metabolic disorders, particularly diabetes mellitus (Type I and Type II) or obesity.
Patent NZ-604004-A (NZ)
Title: Pyridone and aza-pyridone compounds and methods of use
Inventor: BARBOSA ANTONIO J M
IPC: A61K31/498
Filed: 2011-05-06
Abstract: 604004 Disclosed herein is a compound of formula I, wherein the variables are defined herein, and a pharmaceutical composition comprising said compound, a method of making said pharmaceutical composition and the use in the treatment of immune disorders, cancer, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders, and neurological disorders, and wherein the medicament mediates the Bruton’s tyrosine kinase. Specific embodiments of the compound include the following: 5-[2-(hydroxymethyl)-3-[1-methyl-6-oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridin-3-yl ]phenyl] -8-thia-5-azatricyclo[7.4.0.02,7]trideca-1(9),2(7)-dien-6-one; 2-(3-(5-(6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-2-ylamino)-1-methyl-6-oxo-1,6-dihydropyidin-3-yl)-2-(hydroxymethyl)phenyl)-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-1(2H)-one; and 2-(6-fluoro-2-(hydroxymethyl)-3-(1-methyl-5-(5-(4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-ylamino)-6-oxo-1,6-dihydropyridin-3-yl)phenyl)-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-1(2H)-one.
Patent NZ-611224-A (NZ)
Title: Novel endophytes
Inventor: SPANGENBERG GERMAN
IPC: A01H15/00
Filed: 2013-05-30
Abstract: A substantially purified or isolated endophyte having a desired toxin profile, wherein the endophyte produces significantly less toxic alkaloids compared with a control endophyte and/or significantly more alkaloids conferring beneficial properties compared with a control endophyte, wherein said control endophyte is standard toxic endophyte; and wherein said endophyte is selected from the group consisting of NEA16, NEA17, NEA18, NEA19, NEA20, NEA21 and NEA23, as deposited at the National Measurement Institute with accession numbers V12/001413, V12/001414, V12/001415, V12/001416, V12/001417, V12/001418 and V12/001419, respectively.
Patent NZ-612796-A (NZ)
Title: A ca6 antigen-specific cytotoxic conjugate and methods of using the same
Inventor: PAYNE GILLIAN
IPC: C12N5/06
Filed: 2004-07-21
Abstract: Disclosed is an antibody or epitope-binding fragment thereof comprising a heavy chain variable region or fragment thereof and a light chain variable region or fragment thereof; wherein said heavy chain variable region or fragment thereof comprises three sequential complementarity-determining regions having amino acids SYNMH, YIYPGNGATNYNQKFQG and GDSVPFAY of SEQ ID NO:11; wherein said light chain variable region or fragment thereof comprises three sequential complementarity-determining regions having amino acids SAHSSVSFMH, STSSLAS, QQRSSFPLT of SEQ ID NO:8; wherein said antibody binds a CA6 glycotope, and wherein the sequences are as defined in the complete specification.
Patent NZ-619612-A (NZ)
Title: Passive damper
Inventor: MUALLA IMAD H
IPC: E04H9/02
Filed: 2012-07-12
Abstract: A passive damper 1 for dampening relative movement between members 2,3 of a structure to which the damper 1 can be connected, comprises a first set of parallel disposed plates 17, and a second set of parallel disposed plates 18. The first set of plates and the second set of plates overlap one another in an alternating fashion at a rotational joint with damping pads 25 between the plates 17, 18. The rotational joint comprises a pin or bolt 19 inserted through apertures 24 in the plates 17, 18. The apertures 24a in selected plates 18 are shaped and dimensioned to provide a predetermined amount of clearance with the pin or bolt 19 so that the pin or bolt 19 can move inside the aperture 24a to a predetermined extent without the selected plates 18 taking part in the damping action.
Patent NZ-620282-A (NZ)
Title: Thermosensitive recording label
Inventor: IKEDA TOSHIAKI
IPC: G09F3/10
Filed: 2012-10-30
Abstract: Disclosed is a liner-less thermosensitive recording label, which contains a base substrate layer (e.g., paper) with, an under layer (e.g., styrene-butadiene copolymer), a thermosensitive colouring layer (e.g., leuco dye), a barrier layer (e.g., polyvinyl alcohol), and a release layer (e.g., silicone resin) on one side and an adhesive (e.g., acrylic adhesive) layer on the other. The label is rolled so as to contact the adhesive and the release layers so as to avoid the requirement of a liner on the adhesive layer. The release layer contains a cured product of a heat curing silicone resin, and the barrier layer contains a cured product of a water-soluble resin with a crosslinking agent, and an inorganic filler.
Patent NZ-627721-A (NZ)
Title: Liquid delivery tank with expansion chamber
Inventor: COMINELLI TOM
IPC: A47J31/54
Filed: 2013-02-04
Abstract: A beverage making system with an expansion chamber above a heating tank is described. The chamber (117) forms a spiral or otherwise tortuous path between a liquid/air outlet (118a) and an air inlet (118b). A beverage is brewed using water or other liquid boiled in the tank (118) and the remaining vapour that collects in the chamber is removed through the outlet (118a) by the introduction of air at the inlet (118b). The system reduces unwanted discharge of liquid by expelling the vapour before it can condense and drip from the brewing chamber (49).
Patent NZ-629127-A (NZ)
Title: Adjustable mounting device for a sliding element and sliding device
Inventor: ETTMÜLLER PETER
IPC: E05D15/06
Filed: 2014-08-22
Abstract: A mounting device with a connecting bolt, with which a plate-shaped sliding element is connectable to a carriage that is held displaceable in a running rail, the mounting device comprising a holding rail, which is mountable in a recess provided at the upper side of the sliding element, and a holding device that is held releasably in the holding rail and that comprises a bearing device, in which an adjustment screw is rotatably held, which adjustment screw comprises a screw shaft that, aligned along its screw axis, engages in a threaded member of a track body, which is movable along the screw axis and which comprises two track walls that are aligned in parallel to one another and that comprise each a track element, in which guide elements are engaged that are connected to the connecting bolt, which is held in a guide member displaceable along a guide axis, wherein a track sledge is provided that is equipped on opposite sides with the guide elements that are engaged in the track element of the track body and wherein the connecting bolt comprises a first connecting part that is held in the track sledge, a second connecting part that is held in the guide member and a third connecting part that is connectable to the carriage.
Patent NZ-704914-A (NZ)
Title: Beverage comprising a specific milk component, and method of producing the same
Inventor: UENO HIROSHI
IPC: A23L2/38
Filed: 2012-07-31
Abstract: The present invention addresses the problem of providing a safe and novel beverage which is useful in the prevention and treatment of various bone disorders such as osteoporosis, bone fractures, rheumatism, and arthritis when taken on a daily basis. A beverage containing more than 0.8 mg/100 ml and 150 mg/100 ml or less of angiogenin and/or an angiogenin degradation product, and cystatin and/or a cystatin degradation product at a mass ratio of 0.006 to 1.7 relative to the angiogenin and/or angiogenin degradation product. It is possible to strengthen bones and to prevent and treat various bone disorders such as osteoporosis, bone fractures, rheumatism, and arthritis by taking said beverage.
Patent NZ-714979-A (NZ)
Title: Control system for a mobility aid
Inventor: GRIMMER ALAN JOHN
IPC: B25J9/00
Filed: 2009-07-01
Abstract: Disclosed is a method for controlling an exoskeleton worn by a user and having one or more actuators associated with various body members of the exoskeleton each corresponding to a body part of the user. The method comprising the steps of: receiving input data indicative of a desired movement sequence; obtaining from memory pre-programmed movement data indicative of one or more sequential instructions required to effect the movement sequence, each instruction being associated with relative actuator movements for performing the instruction; moving the one or more actuators according to the relative actuator movements for each instruction; and periodically balancing the exoskeleton during movement of the one or more actuators according to a current instruction. The balancing is performed by: determining an actual centre of pressure location at an underside of at least one grounded foot member of the exoskeleton based on input pressure data indicative of pressure at one or more regions of the foot; obtaining a desired centre of pressure location associated with a current instruction to which the one or more actuators move according to; and moving one or more actuators associated with an orientation of the grounded foot member to a position which shifts the actual centre of pressure under the foot towards the desired centre of pressure for the current instruction.
Patent NZ-715456-A (NZ)
Title: Pyrimidinedione compounds against cardiac conditions
Inventor: OSLOB JOHAN
IPC: C07D403/04
Filed: 2014-06-19
Abstract: Provided are novel pyrimidine dione compounds of formula (I) and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.
Patent NZ-728019-A (NZ)
Title: Antibodies binding axl
Inventor: PARREN PAUL
IPC: C07K16/28
Filed: 2015-07-10
Abstract: The present disclosure relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions.
Patent NZ-744591-A (NZ)
Title: Stepless transmission capable of operating continuously
Inventor: HSIN-LIN CHENG
IPC: F16H15/52
Filed: 2018-07-24
Abstract: A stepless transmission capable of operating continuously having a supportive rotating element; a plurality of transmission spheres disposed on the supportive rotating element; a plurality of driving rods rotatably connected to the transmission spheres; a power input clamping rotating element; a power output clamping rotating element, wherein the transmission spheres are disposed between the power input clamping rotating element, power output clamping rotating element and supportive rotating element; an accelerating planet gear train; a first decelerating planet gear train; a transmission shaft; a first one-way transmission rotating element connected between the transmission shaft and a carrier of the planet gear train; a second one-way transmission rotating element connected between the carrier of the planet gear train and a first carrier of the first decelerating planet gear train. Therefore, the stepless transmission capable of operating continuously to transmit power instantly and steadily.
Patent NZ-759653-A (NZ)
Title: Measurement of a mass flow rate
Inventor: HARTMANN ROBERT
IPC: G01G1/00
Filed: 2018-07-18
Abstract: The invention relates to a method and system for determining a specific mass flow rate of a highly viscous food product (1) having a viscosity of greater than 100 c P, which during processing in a continuous delivery flow is fed to or removed from a buffer container (2) by means of a delivery pump (4), wherein a weighing device (7) is used to determine the change in the mass of the food product (1) in the buffer container (2) over a defined time period, which is more particularly in the range of one or several minutes (∆m/∆t), wherein in the same period a pump parameter of the delivery pump (4) that is proportional to the expected delivery rate is registered, wherein changes in the pump parameter over the time period are averaged to form an average pump parameter, and wherein the current specific mass flow rate is calculated as a quotient from the change over time of the mass ∆m/∆t and the averaged pump parameter and is output.
Patent NZ-770742-A (NZ)
Title: Hydrazide containing nuclear transport modulators and uses thereof
Inventor: SANDANAYAKA VINCENT
IPC: C07D409/12
Filed: 2012-07-26
Abstract: The disclosure relates to a family of nuclear transport modulators (CRM1 inhibitors) with a general formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of the unspecified functional groups are described within the specification. The disclosure also relates to the use these compounds for the treatment of disorders such as proliferative disorder, an inflammatory disorder, an autoimmune disorder, a viral infection, an ophthalmological disorder, a neurodegenerative disorder, a disorder of abnormal tissue growth, a disorder related to food intake, allergies, cancer and a respiratory disorder and methods of manufacturing these compounds.
Patent RU-94013760-A (RU)
Inventor: MASKAEV G V
IPC: F41H9/10
Filed: 1994-04-19
Abstract: FIELD: individual irritative protective means. SUBSTANCE: device has irritative pots in form of cigars with detonator heads actuated by friction bar on cigar pack cover which have elements for reactive formation of long-range irritative jet. EFFECT: enhanced efficiency.
Patent RU-94017337-A (RU)
Inventor: PLAKSEJCHUK A JU
IPC: A61B17/56
Filed: 1994-05-10
Abstract: FIELD: medicine; orthopedics. SUBSTANCE: to prepare the proximal fragment for rotatory osteotomy, formed along the axis of the neck of the femur is free cylindrical graft from the trochanterian to subcapital part of the neck. The graft is withdrawn with formation of regenerate to the basal part of the neck. Then, rotary osteotomy is effected and the extremity is fixed in the apparatus of external fixation. EFFECT: treatment of patients ill with ASEPTIC necrosis of the femur head, defects of the upper pole of the head of different etiology. 1 cl, 4 dwg